UA-Related Firms Receive First Local Venture Capital Investments
Codelucida and Regulonix were formed to commercialize inventions stemming from UA research in engineering and medicine.
Sinfonia Healthcare CEO Fletcher McCusker, right, speaks at the 2018 Tech Launch Arizona I-Squared Awards, where he was honored with the award for Ecosystem Impact. TLA Assistant Vice President Doug Hockstad looks on. (Photo: Paul Tumarkin/Tech Launch Arizona)
UAVenture Capital Fund LLC, the Tucson-based early-stage capital fund dedicated to the commercialization of University of Arizona science and technology, has announced its first three portfolio investments.
Each has a strong connection to the UA: Codelucida and Regulonix were formed to commercialize inventions stemming from UA research in engineering and medicine, respectively. The third was started by a graduate of the Eller College of Management.
Codelucida is a UA startup commercializing error-correction technology for data storage and communications. The technology was jointly developed during the doctoral studies of co-founder and CEO Shiva Planjery, along with his co-founders and doctoral advisers Bane Vasic, a UA professor of electrical and computer engineering, and David Declercq.
